NDA is a world-leading regulatory and drug development company, with 25 years of excellence, an extensive portfolio of services, and more than 1600 clients. Over the last three years, NDA Group has supported a quarter of the new medicinal products approved in the US and Europe. Our dedicated team of over 150 consultants combined with the unique NDA Advisory Board provide drug developers with unmatched regulatory expertise, ensuring the safe development of complex & innovative treatments that meet the rigorous requirements of the regulatory agencies. We are a genuine part of our client’s story, and we are a true regulatory partner with one goal in mind, to benefit our client, and ultimately, the patient.